Melanie Kirkby
Ottawa, ON K1H8M5, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Natural Killer Cell-Derived Extracellular Vesicles Exhibit Cytotoxicity Against Bulk Tumor Cells and Cancer Stem Cells in Triple-Negative Breast Cancer.
Journal: Nanomaterials (Basel, Switzerland)
Published: March 16, 2026
Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicity.
Journal: Molecular therapy. Oncology
Published: December 16, 2025
Ultracentrifugation and Ultrafiltration Differentially Alter the Composition and Functionality of the Biomolecular Corona of Extracellular Vesicles.
Journal: Journal of extracellular biology
Published: October 21, 2025
Nanoparticle-Mediated mRNA Delivery to Triple-Negative Breast Cancer (TNBC) Patient-Derived Xenograft (PDX) Tumors.
Journal: ACS pharmacology & translational science
Published: October 11, 2024
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-derived Extracellular Vesicle-based Cancer Biotherapeutics.
Journal: Journal of visualized experiments : JoVE
Published: September 02, 2024
Nanoparticles Codelivering mRNA and SiRNA for Simultaneous Restoration and Silencing of Gene/Protein Expression In Vitro and In Vivo.
Journal: ACS nanoscience Au
Published: July 13, 2024
Evaluation of resazurin phenoxazine dye as a highly sensitive cell viability potency assay for natural killer cell-derived extracellular vesicle-based cancer biotherapeutics.
Journal: Journal of extracellular biology
Published: April 13, 2024
Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model.
Journal: Frontiers in immunology
Published: January 05, 2024
The Potential of Hormonal Therapies for Treatment of Triple-Negative Breast Cancer.
Journal: Cancers
Published: September 08, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026